Serina Therapeutics, Inc.SERNYSE
Loading
Year-over-year operating cash flow growth rate
Percentile
P38
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -2.67% |
| Q2 2025 | 13.23% |
| Q1 2025 | 5.82% |
| Q4 2024 | -54.93% |
| Q3 2024 | 63.02% |
| Q2 2024 | -407.86% |
| Q1 2024 | -1403.31% |
| Q4 2023 | 111.82% |
| Q3 2023 | -18.52% |
| Q2 2023 | -21.86% |
| Q1 2023 | 46.33% |
| Q4 2022 | -6.88% |
| Q3 2022 | 29.21% |
| Q2 2022 | -6.72% |
| Q1 2022 | 0.67% |
| Q4 2021 | 12.58% |
| Q3 2021 | -11.22% |
| Q2 2021 | 35.59% |
| Q1 2021 | -62.35% |
| Q4 2020 | 14.24% |
| Q3 2020 | 15.82% |
| Q2 2020 | -8.72% |
| Q1 2020 | 14.39% |
| Q4 2019 | -1.64% |
| Q3 2019 | 14.03% |
| Q2 2019 | -5.39% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 17.49% |
| Q2 2018 | -7.78% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 69.40% |
| Q2 2017 | -10.86% |
| Q1 2017 | 0.00% |